Response of PUVA-induced keratoses to etretinate.
Hudson-Peacock
M J
MJ
Department of Dermatology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Angus
B
B
Farr
P M
PM
D000328:Adult; D004817:Epidermis / Q000473:pathology; D005050:Etretinate / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007642:Keratosis / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy / Q000473:pathology; D012008:Recurrence; D012074:Remission Induction; D012867:Skin / Q000473:pathology
D007641:Keratolytic Agents; D005050:Etretinate